FCPA/Anti-bribery compliance

Large pharmaceutical and medical device company

Our attorneys undertook an assessments to evaluate compliance effectiveness in various discrete programs and functions, including advisory boards, speaker programs, consulting relationships, medical affairs, and customer relationship databases. In addition, our attorneys conducted overall program evaluations for subsidiaries in Latin America, Asia, Europe, and the Middle East.

Email Disclaimer